Schedule of calculation of basic and diluted net loss per share |
As the Company uses the two-class method required for companies with multiple classes of the common stock, the following table presents the calculation of basic and diluted net loss per share for each class the Company’s common stock (in thousands, except share and per share amounts): | | | | | | | | | | | Three months ended March 31, 2021 | | | | | | | | | | | | | | | | | | | Total | | | | Class A | | Class B | | Common Stock | | Numerator: | | | | | | | | | | | Allocation of undistributed earnings | | $ | (598) | | $ | (92) | | $ | (690) | | Numerator for basic and dilutive EPS – loss available to common stockholders | | $ | (598) | | $ | (92) | | $ | (690) | | Denominator: | | | | | | | | | | | Weighted-average common shares outstanding | | | 91,822,338 | | | 14,094,368 | | | 105,916,706 | | Denominator for basic and dilutive EPS – weighted-average common stock | | | 91,822,338 | | | 14,094,368 | | | 105,916,706 | | Basic and dilutive loss per share | | $ | (0.01) | | $ | (0.01) | | $ | (0.01) | | | | | | | | | | | | | Three months ended March 31, 2020 | | | | | | | | | | | | | | | | | | | Total | | | | Class A | | Class B | | Common Stock | | Numerator: | | | | | | | | | | | Allocation of undistributed earnings | | $ | (24,354) | | $ | — | | $ | (24,354) | | Numerator for basic and dilutive EPS – loss available to common stockholders | | $ | (24,354) | | $ | — | | $ | (24,354) | | Denominator: | | | | | | | | | | | Weighted-average common shares outstanding | | | 5,979,232 | | | — | | | 5,979,232 | | Denominator for basic and dilutive EPS – weighted-average common stock | | | 5,979,232 | | | — | | | 5,979,232 | | Basic and dilutive loss per share | | $ | (4.07) | | $ | — | | $ | (4.07) | |
|
Schedule of anti-dilutive common equivalent shares |
| | | | | | | | Three months ended March 31, | | | | 2021 | | 2020 | | Outstanding options to purchase common stock | | 21,979,733 | | 18,248,540 | | Outstanding restricted stock units | | 3,442,557 | | — | | Outstanding warrants | | 20,653,333 | | — | | Outstanding convertible preferred stock (Series A through D) | | — | | 107,197,118 | | Total anti-dilutive common equivalent shares | | 46,075,623 | | 125,445,658 | |
|